Catalent Cell & Gene Therapy

Baltimore,  MD 
United States

Paragon Gene Therapy, part of Catalent Biologics, is committed to strong client partnerships, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, and oncology immunotherapies. Paragon Gene Therapy has five locations in Maryland dedicated to process development through commercial manufacturing of most scalable AAV platforms across multiple serotypes.